A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
Clinical trial NCT06522737 · RECRUITING
Trial details
- NCT number
- NCT06522737
- Sponsor
- SecuraBio
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-19
- Primary completion
- 2028-02-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.